Stocktoria
Fulcrum Therapeutics, Inc. FULC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-07-18
Fulcrum Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,798,522 | $29.8M |
| Point72 Asset Management, L.P. | 2,074,855 | $15.9M |
| D. E. Shaw & Co., Inc. | 1,623,281 | $12.5M |
| CITADEL ADVISORS LLC | 1,350,686 | $10.4M |
| AQR CAPITAL MANAGEMENT LLC | 543,165 | $4.2M |
| MILLENNIUM MANAGEMENT LLC | 356,471 | $2.7M |
| TWO SIGMA INVESTMENTS, LP | 139,000 | $1.1M |
| RENAISSANCE TECHNOLOGIES LLC | 13,600 | $104,312 |
Source: SEC EDGAR filings · CIK 0001680581 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.